| - GRCh37:
- Chr1:19018263
- GRCh38:
- Chr1:18691769
| PAX7 | E199G, E201G | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:21771581
- GRCh38:
- Chr1:21445088
| NBPF3 | M1T | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:23885773
- GRCh38:
- Chr1:23559282
| ID3 | S49T | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:31532185
- GRCh38:
- Chr1:31059338
| PUM1 | D77H | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45797182
- GRCh38:
- Chr1:45331510
| MUTYH | S269fs, S292fs, S384fs, S385fs, S395fs, S399fs, S409fs, S412fs | Hereditary breast ovarian cancer syndrome | Likely pathogenic (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45798458
- GRCh38:
- Chr1:45332786
| MUTYH | R185W, R65W, R158W, R168W, R172W, R157W, R182W, R42W | Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2, not provided
| Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:45799143
- GRCh38:
- Chr1:45333471
| MUTYH | R97Q, R84Q, R70Q, R69Q, R94Q, R80Q | not specified, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2, Familial cancer of breast, not provided | Conflicting interpretations of pathogenicity (Mar 8, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:46521611
- GRCh38:
- Chr1:46055939
| P3R3URF-PIK3R3, PIK3R3 | R266H, R312H, R283H, R110H, R222H, R185H | Familial cancer of breast | Uncertain significance (Feb 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr1:46714242
- GRCh38:
- Chr1:46248570
| RAD54L | D21G | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46715676
- GRCh38:
- Chr1:46250004
| RAD54L | P32R | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Oct 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:46715725
- GRCh38:
- Chr1:46250053
| RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46724361
- GRCh38:
- Chr1:46258689
| RAD54L | A72P | Familial cancer of breast | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46725615
- GRCh38:
- Chr1:46259943
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46725716
- GRCh38:
- Chr1:46260044
| RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46725730
- GRCh38:
- Chr1:46260058
| RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46726266
- GRCh38:
- Chr1:46260594
| RAD54L | R154W | Hereditary breast ovarian cancer syndrome | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46726320
- GRCh38:
- Chr1:46260648
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46726525
- GRCh38:
- Chr1:46260853
| RAD54L | R202C, R22C | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46726876
- GRCh38:
- Chr1:46261204
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46726933
- GRCh38:
- Chr1:46261261
| RAD54L | E256V, E76V | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Sep 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46727028
- GRCh38:
- Chr1:46261356
| RAD54L | G108fs, G288fs | Familial cancer of breast | Uncertain significance (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46733105
- GRCh38:
- Chr1:46267433
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46733133
- GRCh38:
- Chr1:46267461
| RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46733336
- GRCh38:
- Chr1:46267664
| RAD54L | | Hereditary breast ovarian cancer syndrome | Benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46733359
- GRCh38:
- Chr1:46267687
| RAD54L | | Hereditary breast ovarian cancer syndrome | Benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46736382
- GRCh38:
- Chr1:46270710
| RAD54L | R185Q, R365Q | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46736426
- GRCh38:
- Chr1:46270754
| RAD54L | R200W, R380W | Hereditary breast ovarian cancer syndrome, Premature ovarian failure | Conflicting interpretations of pathogenicity (Apr 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:46738282
- GRCh38:
- Chr1:46272610
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46738306-46738307
- GRCh38:
- Chr1:46272634-46272635
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46738349
- GRCh38:
- Chr1:46272677
| RAD54L | T237I, T417I | Familial cancer of breast | Uncertain significance (Dec 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46738398
- GRCh38:
- Chr1:46272726
| RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46738506
- GRCh38:
- Chr1:46272834
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739042-46739044
- GRCh38:
- Chr1:46273370-46273372
| RAD54L | D285del, D465del | Hereditary breast ovarian cancer syndrome | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739221
- GRCh38:
- Chr1:46273549
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739285
- GRCh38:
- Chr1:46273613
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739332
- GRCh38:
- Chr1:46273660
| RAD54L | T328I, T508I | Hereditary breast ovarian cancer syndrome | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739409
- GRCh38:
- Chr1:46273737
| RAD54L | R354C, R534C | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Benign/Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46739739
- GRCh38:
- Chr1:46274067
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739752
- GRCh38:
- Chr1:46274080
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739754
- GRCh38:
- Chr1:46274082
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739755
- GRCh38:
- Chr1:46274083
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46739814
- GRCh38:
- Chr1:46274142
| RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46740268
- GRCh38:
- Chr1:46274596
| RAD54L | I403T, I583T | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46740289
- GRCh38:
- Chr1:46274617
| RAD54L | M410T, M590T | Inborn genetic diseases, Familial cancer of breast | Uncertain significance (Jan 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46743645
- GRCh38:
- Chr1:46277973
| LRRC41, RAD54L | H496Y, H676Y | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Apr 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:46743738
- GRCh38:
- Chr1:46278066
| LRRC41, RAD54L | | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46743773
- GRCh38:
- Chr1:46278101
| LRRC41, RAD54L | R508H, R688H | Hereditary breast ovarian cancer syndrome | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:46743900
- GRCh38:
- Chr1:46278228
| LRRC41, RAD54L | | Inborn genetic diseases, Hereditary breast ovarian cancer syndrome | Benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:46743907
- GRCh38:
- Chr1:46278235
| LRRC41, RAD54L | F553V, F733V | Hereditary breast ovarian cancer syndrome | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:120539916
- GRCh38:
- Chr1:119997293
| NOTCH2 | P152L | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:146743928
- GRCh38:
- Chr1:147272267
| CHD1L | L138P, L215P, L256P, L267P, L306P, L319P, L347P, L419P | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:159032484
- GRCh38:
- Chr1:159062694
| AIM2 | | not provided, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Aug 1, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:193099337
- GRCh38:
- Chr1:193130207
| CDC73 | R91* | Familial cancer of breast, Hyperparathyroidism 1, Parathyroid carcinoma
| Pathogenic (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:242023882
- GRCh38:
- Chr1:241860580
| EXO1 | G274R | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:32733184
- GRCh38:
- Chr2:32508117
| BIRC6 | L3279F, L3280F | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47601012
- GRCh38:
- Chr2:47373873
| EPCAM | P84S | Hereditary breast ovarian cancer syndrome | Uncertain significance (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47601150
- GRCh38:
- Chr2:47374011
| EPCAM | D130Y | Hereditary breast ovarian cancer syndrome | Uncertain significance (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47606171
- GRCh38:
- Chr2:47379032
| EPCAM | V212G | Hereditary breast ovarian cancer syndrome | Uncertain significance (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47630344
- GRCh38:
- Chr2:47403205
| MSH2 | P5Q | not specified, Hereditary breast ovarian cancer syndrome, Ovarian cancer, not provided, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Feb 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47630410
- GRCh38:
- Chr2:47403271
| MSH2 | P27L | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome, Lynch syndrome 1, Hereditary cancer-predisposing syndrome, Lynch syndrome
| Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47630448
- GRCh38:
- Chr2:47403309
| MSH2 | G40S | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome, not provided | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47635594
- GRCh38:
- Chr2:47408455
| MSH2 | V89A, V23A | Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not specified, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47635614
- GRCh38:
- Chr2:47408475
| MSH2 | R96C, R30C | Breast-ovarian cancer, familial, susceptibility to, 1, not specified, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637314
- GRCh38:
- Chr2:47410175
| MSH2 | V150F, V84F | Hereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome
| Conflicting interpretations of pathogenicity (Aug 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637371
- GRCh38:
- Chr2:47410232
| MSH2 | I169V, I103V | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47655013-47657819
- GRCh38:
- Chr2:47427874-47430680
| MSH2 | | Endometrial carcinoma, Turcot syndrome, Lynch syndrome 5, Lynch syndrome 1, Familial cancer of breast | Pathogenic (Aug 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47657059
- GRCh38:
- Chr2:47429920
| MSH2 | Q419K, Q353K | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47672725
- GRCh38:
- Chr2:47445586
| MSH2 | P439A, P373A | Hereditary cancer-predisposing syndrome, not provided, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms | Conflicting interpretations of pathogenicity (Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47690284
- GRCh38:
- Chr2:47463145
| MSH2 | R435G, R501G | Hereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47693924
- GRCh38:
- Chr2:47466785
| MSH2 | K546N, K480N | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Hereditary breast ovarian cancer syndrome
| Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47702250
- GRCh38:
- Chr2:47475111
| MSH2 | P616S, P550S | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Sep 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47703564
- GRCh38:
- Chr2:47476425
| MSH2 | M688I, M622I | Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided, not specified, Lynch syndrome 1
| Conflicting interpretations of pathogenicity (Feb 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47703709
- GRCh38:
- Chr2:47476570
| MSH2 | R737G, R671G | Hereditary breast ovarian cancer syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47705607
- GRCh38:
- Chr2:47478468
| MSH2 | T803A, T737A | not specified, Hereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47705625
- GRCh38:
- Chr2:47478486
| MSH2 | E809K, E743K | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Nov 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47707909
- GRCh38:
- Chr2:47480770
| MSH2 | K845E, K779E | Hereditary cancer-predisposing syndrome, not specified, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Lynch syndrome 1
| Conflicting interpretations of pathogenicity (Sep 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48010602
- GRCh38:
- Chr2:47783463
| MSH6 | R77Q | Hereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jan 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48010605
- GRCh38:
- Chr2:47783466
| MSH6 | R78K | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 5, not specified, Hereditary breast ovarian cancer syndrome | Uncertain significance (Sep 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48023107
- GRCh38:
- Chr2:47795968
| MSH6 | R178C | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome, Lynch syndrome 5, not specified
| Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48025850
- GRCh38:
- Chr2:47798711
| MSH6 | R243H, R113H | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome, Lynch syndrome | Conflicting interpretations of pathogenicity (Mar 7, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48026194
- GRCh38:
- Chr2:47799055
| MSH6 | D228N, D358N, D56N | Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome | Uncertain significance (Dec 8, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48026260
- GRCh38:
- Chr2:47799121
| MSH6 | D250N, D380N, D78N | Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48026312
- GRCh38:
- Chr2:47799173
| MSH6 | Y397C, Y267C, Y95C | Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary breast ovarian cancer syndrome, Lynch syndrome 5, Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5, not specified, Lynch syndrome | Conflicting interpretations of pathogenicity (Dec 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48026782
- GRCh38:
- Chr2:47799643
| MSH6 | R554C, R252C, R424C | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, Hereditary breast ovarian cancer syndrome | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48027348
- GRCh38:
- Chr2:47800209
| MSH6 | N742K, N612K, N440K | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, not provided | Uncertain significance (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027419
- GRCh38:
- Chr2:47800280
| MSH6 | H464L, H636L, H766L | Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome | Uncertain significance (May 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48027671
- GRCh38:
- Chr2:47800532
| MSH6 | Y850S, Y720S, Y548S | Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome | Uncertain significance (May 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028007
- GRCh38:
- Chr2:47800868
| MSH6 | I962T, I832T, I660T | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, Hereditary breast ovarian cancer syndrome | Uncertain significance (Nov 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028265
- GRCh38:
- Chr2:47801126
| MSH6 | Q918R, Q1048R, Q746R | Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome, Hereditary nonpolyposis colorectal neoplasms
| Uncertain significance (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48028273
- GRCh38:
- Chr2:47801134
| MSH6 | V1051I, V749I, V921I | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, not specified, Hereditary breast ovarian cancer syndrome, Lynch syndrome 5
| Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48032851
- GRCh38:
- Chr2:47805712
| MSH6 | | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Familial cancer of breast
| Uncertain significance (May 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033385
- GRCh38:
- Chr2:47806246
| MSH6 | A1230G, A1100G, A928G | Hereditary nonpolyposis colorectal neoplasms, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Sep 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:48033763
- GRCh38:
- Chr2:47806624
| MSH6 | K1325T, K1195T, K1023T | Breast-ovarian cancer, familial, susceptibility to, 1, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48033792-48033795
- GRCh38:
- Chr2:47806653-47806656
| MSH6 | | Lynch syndrome | Likely benign (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:79971512
- GRCh38:
- Chr2:79744386
| CTNNA2 | | Hereditary breast ovarian cancer syndrome | Pathogenic (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505328
- GRCh38:
- Chr2:178640601
| TTN | E10987*, E11914*, E13555*, E4490*, E4615*, E4682* | Familial cancer of breast | Likely pathogenic (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:190708712
- GRCh38:
- Chr2:189843986
| PMS1 | R202K, R141K, R26K | Hereditary breast ovarian cancer syndrome | Likely benign (May 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:190719037
- GRCh38:
- Chr2:189854311
| PMS1 | E171K, E286K, E308K, E347K | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:190719607
- GRCh38:
- Chr2:189854881
| PMS1 | E537K, E361K, E476K, E498K | not specified, Hereditary breast ovarian cancer syndrome | Likely benign (Jul 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:202136272
- GRCh38:
- Chr2:201271549
| CASP8 | | Autoimmune lymphoproliferative syndrome type 2B, Familial cancer of breast, Lung cancer, Hepatocellular carcinoma, Autoimmune lymphoproliferative syndrome type 2B | Benign/Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |